Calumet Specialty Products Partners (CLMT)
Official siteBASIC MATERIALS • SPECIALTY CHEMICALS • NASDAQ
Market Cap: $3.02B
Last updated: Nov 17, 2026 at 4:20 PM ET
Calumet Specialty Products Partners (CLMT) Statistics
Calumet Specialty Products Partners (CLMT) has a market cap of $3.02B and an enterprise value of $4.97B. Revenue grew 28.37% over the last 12 months from the 12 months before. Its net debt of $1.95B equals 64.43% of its market cap.
Total Valuation
Enterprise value is 64.43% above the market cap, as debt exceeds cash.
| Market Cap | $3.02B |
|---|---|
| Enterprise Value | $4.97B |
| Latest price (Nov 17, 2026) | $31.82 |
Key Dates
The next earnings report is expected on Feb 25, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 25, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 6, 2026 |
| Fiscal Year End | December |
Valuation Ratios
The price to sales ratio is 0.5x.
| P/E Ratio | 8.4x |
|---|---|
| P/S Ratio | 0.5x |
| Forward P/S | 0.6x |
| P/FCF Ratio | 10.6x |
| P/OCF Ratio | 8.9x |
Enterprise Valuation
Counting debt and cash, the company is valued at 17.9x free cash flow.
| EV / Sales | 1.0x |
|---|---|
| EV / FCF | 17.9x |
Price Statistics
The stock is up 70.43% over 52 weeks and trades 37.60% below its 50-day average.
| Beta (1Y) | -0.17 |
|---|---|
| 52-Week Change | +70.43% |
| 1-Month Change | -42.71% |
| 3-Month Change | -35.31% |
| 6-Month Change | -1.27% |
| Total Return (1Y) | +70.43% |
| Return vs SPY (1Y) | +55.21% |
| Max Drawdown (1Y) | -46.11% |
| Max Drawdown (3Y) | -61.87% |
| Sharpe Ratio (1Y) | 1.08 |
| Correlation with SPY (1Y) | -0.05 |
| 50-Day Average | $50.99 |
| 200-Day Average | $39.56 |
| 52-Week Range | $17.85 to $59.87 |
| RSI (14 Days) | 20.4 |
| Average Volume (20 Days) | 1.69M |
Financial Position
Current assets cover 1.06x current liabilities.
| Current Ratio | 1.06x |
|---|---|
| Quick Ratio | 0.66x |
| Debt / EBITDA | 7.94x |
| Debt / FCF | 8.19x |
| Interest Coverage | -0.19x |
Returns and Efficiency
Return on invested capital is -9.80% over the last 12 months, against a 5-year average of 2.33%.
| Return on Assets (ROA) | -6.47% |
|---|---|
| Return on Invested Capital (ROIC) | -9.80% |
| Return on Capital Employed (ROCE) | -10.74% |
| ROA (5Y Average) | -5.15% |
| ROIC (5Y Average) | 2.33% |
| Asset Turnover | 1.81x |
| Inventory Turnover | 10.57x |
| Receivables Turnover | 11.77x |
| Cash Conversion Cycle | 35 days |
Scores
CLMT has an Altman Z-Score of 1.21, in the distress zone below 1.81, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 1.21 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $5.20B over the last 12 months.
| Revenue | $5.20B |
|---|---|
| Revenue Growth (YoY) | +28.37% |
| Gross Profit | $471.00M |
| Operating Income | $179.20M |
| Pretax Income | -$298.70M |
| Net Income | -$193.80M |
| EBIT | -$196.20M |
| Reported EPS (TTM) | $3.78 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $225.20M |
|---|---|
| Total Debt | $2.17B |
| Net Debt | $1.95B |
| Net Debt Per Share | $22.12 |
| Working Capital | $73.90M |
| Shareholder Equity | -$870.70M |
| Total Assets | $2.99B |
| Total Liabilities | $3.60B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $76.00M of capital spending, operating cash flow left $265.10M of free cash flow.
| Operating Cash Flow | $341.10M |
|---|---|
| Capital Expenditures | $76.00M |
| Free Cash Flow | $265.10M |
| FCF Per Share | $3.01 |
| Depreciation and Amortization | $148.80M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 3.45%, against a 5-year average of 1.60%.
| Gross Margin | 9.06% |
|---|---|
| Operating Margin | 3.45% |
| Pretax Margin | -5.75% |
| Net Margin | -3.73% |
| EBIT Margin | -3.78% |
| FCF Margin | 5.10% |
| Gross Margin (5Y Average) | 6.86% |
| Operating Margin (5Y Average) | 1.60% |
| Net Margin (5Y Average) | -3.34% |
Growth
Revenue fell 4.07% a year over 3 years.
| Revenue Growth (3Y CAGR) | -4.07% |
|---|---|
| Revenue Growth (5Y CAGR) | +12.77% |
| FCF Growth (5Y CAGR) | +24.66% |
| Operating Income Growth (3Y CAGR) | -25.66% |
Dividends and Yields
CLMT does not pay a dividend. Its free cash flow yield is 9.46%.
| Earnings Yield | 11.90% |
|---|---|
| FCF Yield | 9.46% |
| Shareholder Yield | 0.00% |
Peer Position
Against 12 similar companies, CLMT has the lowest P/E and the 12th highest P/S.
P/E RatioPeer median 20.0x
P/S RatioPeer median 1.6x
ROICPeer median 7.45%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +8.40%
| P/E Ratio | 8.4x vs 20.0x median |
|---|---|
| P/S Ratio | 0.5x vs 1.6x median |
| ROIC | -9.80% vs 7.45% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +28.37% vs +8.40% median |
Analyst Forecast
Consensus estimates put revenue growth at 9.43% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +9.43% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About CLMT
What is CLMT's market cap?
Calumet Specialty Products Partners has a market cap of $3.02B. Its enterprise value, which adds debt and subtracts cash, is $4.97B.
What is CLMT's P/E ratio?
Calumet Specialty Products Partners has a trailing P/E ratio of 8.4x.
How many shares of CLMT are outstanding?
Calumet Specialty Products Partners has 88.02M shares outstanding. The count is up 1.51% from a year earlier.
Does CLMT pay a dividend?
No. Calumet Specialty Products Partners does not pay a dividend.
How much debt does CLMT have?
Calumet Specialty Products Partners has $2.17B of total debt and $225.20M of cash and equivalents, a net debt position of $1.95B.
CLMT pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors